Long-term Outcomes of Heart Transplantation in Older Recipients

Journal of Heart and Lung Transplantation

Volumn 27, Issue 8, 2008, Pages 830-834

  Marelli, Daniel ^a   Kobashigawa, Jon ^a   Hamilton, Michele A ^a   Moriguchi, Jaime D ^a   Kermani, Reza ^a   Ardehali, Abbas ^a   Patel, Jignesh ^a   Noguchi, Emily ^a   Beygui, Ramin ^a   Laks, Hillel ^a   Plunkett, Mark ^a   Shemin, Richard ^a   Esmailian, Fardad ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; PREDNISONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; GRAFT REJECTION; HEALTH HAZARD; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 47649100713     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.05.006     Document Type: Article

References (14)

1. Organ Procurement and Transplantation Network. Organ by age. United Network for Organ Sharing, 2007. http://www.optn.org/latestData/rptData.asp
2. Morgan J.A., John R., Mancini D.M., and Edwards N.M. Should heart transplantation be considered as a treatment option for patients aged 70 years and older?. J Thorac Cardiovasc Surg 127 (2004) 1817-1819
3. Demers P., Moffatt S., Oyer P.E., et al. Long-term results of heart transplantation in patients older than 60 years. J Thorac Cardiovasc Surg 126 (2003) 224-231
4. Laks H., Marelli D., Fonarow G.C., et al. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg 125 (2003) 49-59
5. Forni A., Faggian G., Chiominto B., et al. Heart transplantation in older candidates. Transplant Proc 39 (2007) 1963-1966
6. Nagendran J., Wildhirt S.M., Modry D., et al. A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: the University of Alberta experience. J Card Surg 19 (2004) 559-562
7. Weiss E.S., Nwakanma L.U., Patel N.D., and Yuh D.D. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant 27 (2008) 184-191
8. Baryalei M., Zenker D., Pieske B., et al. Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine. Transplant Proc 35 (2003) 1539-1542
9. Potter B.J., Giannetti N., Edwardes M.D., Cecere R., and Cantarovich M. Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients. Clin Transplant 21 (2007) 305-308
10. Jerzy S., Wierzbicki K., Kapelak B., et al. Discontinuation of calcineurin inhibitors in heart transplant patients with end stage renal insufficiency as an alternative model of immunosuppression. Przegl Lek 63 (2006) 1256-1258
11. Villar E., Boissonnat P., Sebbag L., et al. Poor prognosis of heart transplant patients with end-stage renal failure. Nephrol Dial Transplant 22 (2007) 1383-1389
12. Roithmaier S., Haydon A.M., Loi S., et al. Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience. J Heart Lung Transplant 26 (2007) 845-849
13. Bradley B.A. Rejection and recipient age. Transplant Immunol 10 (2002) 125-132
14. Deng M.C., Eisen H.J., Mehra M.R., Billingham M., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160